Dr. Harvey D White MB, ChB

Dr.Harvey D.White is now a director of Coronary Care and Cardiovascular Research at Green Lane Hospital in Auckland, New Zealand, and a Honorary Clinical Professor of Medicine at the University of Auckland. He received MBCh B. And Doctorate of Science from the University of Otago, New Zealand in 1973 and 1995 respectively, He started his career as a House Surgeon at Kew Hospital in New Zealand in 1974 and has moved to work at Green Lane Hospital in 1978 as a Cardiology Registrar
Each year, 1.5 to 2 million people worldwide suffer myocardial infarction, and 750,000 to 1 million of these die as a result. In 1987 Dr. White’s study was the first to show that thrombolytic therapy improves left ventricular function. In 1989 Dr. White published a second study comparing streptokinase with tissue plasminogen activator for preservation of left ventricular function. In 1990 he published his study, which showed that readministration was an appropriate strategy in patients with recurrent myocardial infarction. This strategy is now used extensively in clinical practice.
Dr. White has delivered lectures in 27 countries to promote the wider use of thrombolytic therapy, and has comtributed 169 peer-reviewed journal articles, 18 editorials and 22 textbook chapters to the scientific literature. He is also an editorial board member of eight medical journals, including Heart and Circulation, and reviews research papers for 15 journals. As a result of his work, thrombolytic therapy was introduced several years earlier than would otherwise have been possible, and many lives have been saved as a result.